Latest filings (excl ownership)
8-K
Organovo Announces the Issuance of Additional Shares
6 Mar 25
424B5
Prospectus supplement for primary offering
26 Feb 25
8-K
Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company
25 Feb 25
10-Q
2025 Q3
Quarterly report
19 Feb 25
NT 10-Q
Notice of late quarterly filing
14 Feb 25
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Jan 25
8-K
Departure of Directors or Certain Officers
31 Dec 24
8-K
Departure of Directors or Certain Officers
22 Nov 24
10-Q
2025 Q2
Quarterly report
8 Nov 24
S-1
IPO registration
25 Oct 24
ARS
2024 FY
Annual report to shareholders
7 Oct 24
DEFA14A
Additional proxy soliciting materials
7 Oct 24
DEF 14A
Definitive proxy
7 Oct 24
PRE 14A
Preliminary proxy
18 Sep 24
8-K
Departure of Directors or Certain Officers
9 Aug 24
10-Q
2025 Q1
Quarterly report
5 Aug 24
10-K/A
2024 FY
Annual report (amended)
26 Jul 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Jul 24
10-K
2024 FY
Annual report
31 May 24
424B4
Prospectus supplement with pricing info
14 May 24
8-K
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
13 May 24
424B4
Prospectus supplement with pricing info
10 May 24
EFFECT
Notice of effectiveness
9 May 24
8-K
Regulation FD Disclosure
1 May 24
S-1/A
IPO registration (amended)
30 Apr 24
8-K
Other Events
23 Apr 24
S-1
IPO registration
12 Apr 24
EFFECT
Notice of effectiveness
9 Feb 24
424B5
Prospectus supplement for primary offering
8 Feb 24
10-Q
2023 Q3
Quarterly report
8 Feb 24
8-K
Regulation FD Disclosure
7 Feb 24
CORRESP
Correspondence with SEC
6 Feb 24
UPLOAD
Letter from SEC
2 Feb 24
S-3
Shelf registration
26 Jan 24
8-K
Unregistered Sales of Equity Securities
28 Dec 23
424B5
Prospectus supplement for primary offering
22 Dec 23
S-8
Registration of securities for employees
1 Dec 23
10-Q
2023 Q2
Quarterly report
9 Nov 23
8-K
Departure of Directors or Certain Officers
3 Nov 23
8-K/A
Cost Associated with Exit or Disposal Activities
22 Sep 23
Latest ownership filings
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 25
3
Norm Staskey
8 Jan 25
SC 13G
ARMISTICE CAPITAL, LLC
14 Nov 24
4
David Gobel
9 Aug 24
4
Douglas Jay Cohen
9 Aug 24
4
Alison Tjosvold Milhous
9 Aug 24
4
ADAM K STERN
9 Aug 24
4
Vaidehi Joshi
9 Aug 24
4
Keith Murphy
7 Aug 24
SC 13G/A
Nikko Asset Management Americas, Inc.
12 Feb 24
SC 13G/A
Sumitomo Mitsui Trust Holdings, Inc.
5 Feb 24
4
ADAM K STERN
17 Nov 23
4
Alison Tjosvold Milhous
17 Nov 23
4
Douglas Jay Cohen
17 Nov 23
4
Keith Murphy
17 Nov 23
4
David Gobel
17 Nov 23
4
Vaidehi Joshi
17 Nov 23
144
Notice of proposed sale of securities
15 Nov 23
SC 13G/A
Nikko Asset Management Americas, Inc.
10 Feb 23
SC 13G/A
Sumitomo Mitsui Trust Holdings, Inc.
3 Feb 23
4
David Gobel
14 Nov 22
4
ADAM K STERN
14 Nov 22
4
Keith Murphy
14 Nov 22
4
Alison Tjosvold Milhous
14 Nov 22
4
Douglas Jay Cohen
14 Nov 22
4
Vaidehi Joshi
14 Nov 22
4
THOMAS E JURGENSEN
20 Oct 22
4
Jeffrey N. Miner
20 Oct 22
4
Keith Murphy
20 Oct 22
5
David Gobel
8 Jul 22
4
Vaidehi Joshi
10 Mar 22
3
Vaidehi Joshi
10 Mar 22
SC 13G/A
Nikko Asset Management Americas, Inc.
14 Feb 22
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
10 Feb 22
SC 13G/A
Sumitomo Mitsui Trust Holdings, Inc.
4 Feb 22
3
Thomas Hess
1 Nov 21
4
David Gobel
12 Oct 21
4
THOMAS E JURGENSEN
12 Oct 21
4
Jeffrey N. Miner
12 Oct 21
4
Alison Tjosvold Milhous
12 Oct 21